https://www.nap.edu/read/9027/chapter/6
The malaria parasite has multiple, immunologically distinct developmental stages and effective immune avoidance strategies. Single-antigen and single-stage vaccines have proved disappointing. Multi-antigen, multistage vaccines, which elicit different kinds of immune responses directed toward different antigens, appear more promising. High antibody levels can be effective against sporozoites and blood-stage parasites, but a cytotoxic cell response is needed to attack the critical liver stage, and antibodies are clearly needed to block transmission. Selecting the optimal antigens from among the stages in the parasite's life cycle and devising optimal formulations and delivery systems to elicit the desired immunologic response is a complex and difficult task, one that must be based on scientific knowledge, but will also require empirical testing of multiple potential vaccine products.
Remember that a vaccine needs to produce an immune response that doesn’t lead to cytokine storm or devestating autoimmune response.
Not an expert, but it is #25 on that WHO list.
"Recent progress has been made with the completion of a Phase 3 trial of the RTS,S/AS01 candidate vaccine and review by the European Medicines Agency and WHO. There is currently no commercially available malaria vaccine."
[1] https://www.who.int/immunization/research/development/malari...
It's more anecdotal than technical, but interesting nonetheless -- I never would have guessed people were volunteering to be given malaria...